Recursion Pharmaceuticals Inc Cl A
(RXRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 286,668 | 404,954 | 642,970 | 219,130 | 264,126 |
| Marketable Securities | 231,446 | 184,189 | N/A | N/A | N/A |
| Receivables | 9,090 | 2,282 | 49 | 71 | 156 |
| Other current assets | 7,514 | 9,445 | 4,616 | 2,621 | 2,155 |
| TOTAL | $534,718 | $600,870 | $647,635 | $221,822 | $266,437 |
| Non-Current Assets | |||||
| PPE Net | 64,725 | 55,439 | 48,549 | 44,642 | 25,967 |
| Intangibles | 2,186 | 2,262 | 2,338 | 2,414 | 2,490 |
| Other Non-Current Assets | 8,716 | 35 | 68 | 3,065 | 3,691 |
| TOTAL | $75,627 | $57,736 | $50,955 | $50,121 | $32,148 |
| Total Assets | $610,345 | $658,606 | $698,590 | $271,943 | $298,585 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,819 | 6,326 | 3,196 | 3,125 | 1,074 |
| Accrued Expenses | 32,333 | 25,113 | 12,710 | 11,085 | 10,485 |
| Other current liabilities | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 |
| TOTAL | $46,658 | $42,943 | $29,540 | $26,854 | $23,099 |
| Non-Current Liabilities | |||||
| Long Term Debt | 633 | 656 | 9,423 | 10,339 | 11,414 |
| Other Non-Current Liabilities | 16,006 | 12,627 | 14,094 | 16,719 | 19,375 |
| TOTAL | $20,749 | $16,631 | $26,336 | $29,808 | $33,463 |
| Total Liabilities | $67,407 | $59,574 | $55,876 | $56,662 | $56,562 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 170,774 | 168,993 | 168,483 | 168,321 | N/A |
| Common Shares | 2 | 2 | 2 | N/A | N/A |
| Retained earnings | -400,080 | -335,147 | -287,719 | -244,318 | -213,601 |
| Other shareholders' equity | -126 | 2 | 0 | 448,312 | 448,312 |
| TOTAL | $542,938 | $599,032 | $642,714 | $215,281 | $242,023 |
| Total Liabilities And Equity | $610,345 | $658,606 | $698,590 | $271,943 | $298,585 |